“Mediceles Co., Ltd.” is a joint venture between Celes (Thailand) Co., Ltd. and Meditox Inc., the No. 1 high-standard manufacturer of Botulinum Toxin from Korea. It is also the sole importer and distributor of Medicelles Company Limited.
Launched the import of 2 new series of pure fillers (fillers) under the name Neuramis, namely Neuramis DEEP Lidocaine and Neuramis VOLUME Lidocaine, shaking up the medical beauty market. with a continuous high growth rate
Mr. Surawut Wuwong, Chief Executive of Medizeles Co., Ltd., revealed that “Mediceles, we are a joint venture company between Celes and Medytox from Korea (60/40 ratio). market Distribution of pharmaceuticals and medical devices
The product is Neuramis, a type 4 medical device known as a filler that has received standards and registration numbers from the Food and Drug Administration, Thailand, and the country of origin is Korea. In its segment, Meditox is the market leader in biopharmaceuticals. Known for a long time as the drug Neuronox, now Meditox has developed a new generation of biologic drugs. to meet the market that needs safer medicines.”
beauty industry with doctors It is considered the industry with the highest growth in the industry of rising stars. and believe that it will continue to grow every year Because Thai people pay more attention to taking care of their own beauty. Overall, the beauty market with Thai doctors at the moment. Outstanding growth group In the past several years is the filler group. Currently, the filler market is growing more than twice as much as the toxin group. The anti-aging market continues to grow at a normal rate.
Currently, Medizeles has 3 main products, neuramis fillers, for physicians to choose from. for face adjustment to fill in the deep grooves of the face caused by aging for neuronox Currently in the process of re-registering. and evaluating a new set of up-to-date documents The filler group in 2018 had a CAGR of about 15-20% and a specific business growth rate in 2021 compared to 2020 at +30%. In 2022, there are plans to grow. is a +100% rate.”
The company will also focus on marketing both offline, which can reach more doctors and will focus on doing online. Added to focus more easily accessibility.
- Providing academic knowledge to physicians through online lectures such as webinar arrangements and continuing to provide hands-on workshops with the use of state-of-the-art technology tools. For example, the technology of making 3D images with Morpheus machines in Thailand is only used in medical schools. Join to create a picture to understand the final outcome of the treatment.
- Focus on existing customer base Because they are familiar with the product very well. by focusing on giving more privileges As for the sales team, focus on maintaining relationship with customers and building new customer base. such as surgery that takes advantage of The filler is wider
- Use more social media for brand awareness (2nd place in Thailand according to survey) and promote in-depth understanding via Facebook, Line open chat, Line official etc.
Recently with the launch of 2 new Neuramis series, Neuramis DEEP Lidocaine and Neuramis VOLUME Lidocaine, Mr. Surawut said, “To provide more options, physicians or increase customer base such as From the former used in certain areas such as the cheekbones, temples, with the new two, it can create a face shape suitable for age according to the Golden Ratio principle or physiognomy, increasing the amount as needed. will respond to the customer’s needs at the point, such as adjusting the face shape Increased filler durability Reduce pain from injections due to the presence of anesthetic ingredients.
which is the highlight of the new 2 series of new neuramis and because it is registered as a medical device The target group is still general physicians, specialists such as dermatologists, plastic surgeons, cosmetic and reconstructive surgeons, dentists, beauty clinics. In addition, new distribution channels will be expanded. to cover more Currently, there are more than 2,000 beauty clinics using the company’s products nationwide. And more and more from marketing programs that can be used in many areas of the body. So there are many opportunities for our business to grow further.”
However, the company aims In order to become a leader in the Korean filler market in Thailand, all three fillers are registered in Europe according to the CE Mark and EC Certificate standards. Currently, the products are distributed in many countries such as the United Kingdom, Turkey, etc.
It also hopes that the new 2 new models of New Ramis are suitable for all groups of customers, including single clinics, chain clinics, and private hospitals. to help the doctor perform the procedure in detail in every area on the face And with the cooperation of CET, distribution partners can quickly reach the target audience.
This year, the company has plans to market other products. related to the beauty market and health-related products such as Botulinum toxin, a new model that has the advantage of being able to reduce allergic reactions from proteins contained in the product from the original formula that has been sold since 2008, and there are also other products Many interesting species
and because all the time in the past The goods are imported illegally. trademark infringement and product counterfeiting which is dangerous for drug users Therefore, it should be noted that the following inspection methods should be noted:
- The certificate that the company has given to the clinic that has been trained for Confirm that the clinic or medical facility have purchased products from Medicelles which is the sole legal importer and distributor of Neuramis filler products in Thailand
- Scan the QR code on the packaging box. which inside will display product information for both production models Expiration date and a statement confirming that it was purchased through Medicelles who is the sole authorized importer and distributor in Thailand
- Security sticker on the packaging box To build confidence to the service recipient that it is a new product. Not yet activated It also prevents counterfeiting by using the original box.
- The packaging must have a Thai medical device label. and the medical device registration number as prescribed by the FDA
Regarding inquiries regarding the suspension of Neuronox imports in the past, Mr. Surawut clarified that “for Neuronox, a toxin that has been in the hearts of users for a long time, from dissemination from various media About the suspension of imports and recalls The company has shown responsibility to more than 700 customers with immediate recalls, with a product value of more than 110 million baht, completed within 30 working days, and the recalled products were incinerated. to prevent its use.
However, the company is still interested in bringing Neuronox back to the market. because they still believe in quality and product safety This is confirmed by the results of use with more than 500,000 patients in the country during 2008-2020. In addition, the company has conducted additional research studies to prove the efficacy and safety in 180 Thai people in all medical institutions. The research, which began to be published in medical journals in October 2021, shows that Neuronox is accepted among medical professionals.
